#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Acute myeloid leukaemia (in remission) Optic glioma Endometrial adenocarcinoma Non-small cell lung cancer recurrent Shprintzen-Goldberg syndrome Neovascular age-related macular degeneration Glioma Phaeochromocytoma Raynaud's phenomenon Dent's disease Neuroendocrine tumour Hypochondroplasia Antisynthetase syndrome Familial dilated cardiomyopathy Liposarcoma recurrent More trials…

    Learn about Rare Diseases

    Haemolytic uraemic syndrome – Trials in Disease Angiosarcoma metastatic – Diagnostics Shprintzen-Goldberg syndrome Pelizaeus-Merzbacher disease – Diagnostics Mucopolysaccharidosis III – Diagnostics Antithrombin III deficiency – Treatment Mantle cell lymphoma stage III – Treatment Synovial sarcoma recurrent – Treatment Mantle cell lymphoma refractory – Treatment Congenital nephrogenic diabetes insipidus – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Reboxetine Dexlansoprazole Dyp688 Fluticasone Propionate Cpk850 Alanine Magnesium Sulfate Dapagliflozin Regadenoson Ziprasidone Methylprednisolone Nmd670 Evg321 Db-Oto-5 GSK5733584 Afimetoran Besilate Dihydrate DICLOFENAC POTASSIUM Mk-4830 MAPLIRPACEPT Pomalidomide More therapies…

    Learn about Your Condition

    Eructation Anaemia of chronic disease Endometriosis Asymptomatic HIV infection Mesothelioma Laryngeal cancer stage I Renal transplant Benign renal neoplasm Complex regional pain syndrome Hyperplasia adrenal Thrombectomy Hypertrophic cardiomyopathy Deep vein thrombosis Psychotic disorder Giant cell arteritis More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Anesthesia and Analgesia

  • Study on Low Oxygen and Nitrous Oxide Use During Anesthesia for Surgery Patients

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Nitrous Oxide
    • Oxygen
    Sweden
  • Study on Intranasal Dexmedetomidine for Sedation and Pain Relief in Children Undergoing Minor Procedures in the Emergency Room

    Recruiting

    3 1 1
    Investigated Drugs:
    • Dexmedetomidine
    • Sodium Chloride
    Finland
  • Study on Dexmedetomidine and Sodium Chloride for Pain Management in Children Undergoing Surgery with Local Anesthesia

    Recruiting

    2 1 1
    Investigated Drugs:
    • Dexmedetomidine
    • Sodium Chloride
    France
  • Study on Pain Relief After Obesity Surgery Using Esketamine, Dexmedetomidine, and Lidocaine Hydrochloride Monohydrate for Patients Undergoing Obesity Surgery

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Procedural pain
    • Obesity
    Investigated Drugs:
    • Remifentanil Hydrochloride
    • Dexmedetomidine
    • Esketamine
    Sweden
  • Study on Preventing Persistent Postoperative Pain in Children Using Mepivacaine Hydrochloride and Drug Combination

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Procedural pain
    Investigated Drugs:
    • Nalbuphine Hydrochloride
    • Ondansetron Hydrochloride
    • Sevoflurane
    France
  • Study on the Effects of Ketamine on Therapy Intensity and Brain Pressure in Patients with Traumatic Brain Injury

    Recruiting

    3 1 1
    Investigated Diseases:
    • Craniocerebral injury
    Investigated Drugs:
    • Ketamine
    Belgium
Previous Page
1 … 6 7 8 9 10 … 26
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.


European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.

Numer nieprawidłowy!
Numer nieprawidłowy!